# Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines

> **NCT02031679** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 38 (actual)

## Conditions studied

- Chronic Idiopathic Urticaria

## Interventions

- **DRUG:** AZD1981
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02031679
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02031679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02031679, "Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02031679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*